 | • レポートコード：MRC2312MG07538 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の腰椎側方椎体間固定術（XLIF）手術市場規模と予測を収録しています。・世界の腰椎側方椎体間固定術（XLIF）手術市場：売上、2018年-2023年、2024年-2029年 ・世界の腰椎側方椎体間固定術（XLIF）手術市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の腰椎側方椎体間固定術（XLIF）手術市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「XLIF椎体間融合システム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 腰椎側方椎体間固定術（XLIF）手術のグローバル主要企業は、Medtronic Plc、 Johnson & Johnson、 Stryker Corporation、 Zimmer Biomet Holdings Inc.、 NuVasive Inc.、 Globus Medical Inc.、 DePuy Synthes、 B. Braun Melsungen AG、 Alphatec Holdings Inc.、 RTI Surgical Holdings Inc.、 K2M Group Holdings Inc.、 Orthofix Medical Inc.、 Aesculap Implant Systems、 SpineWave Inc.、 MicroPort Scientific Corporation、 Life Spine Inc.、 Captiva Spine Inc.、 CoreLink Surgical LLC、 CTL Medical Corporation、 Providence Medical Technology Inc.、 Safe Orthopaedics、 Spinal Elements Holdings Inc.、 Spineology Inc.、 Wenzel Spine Inc.、 Xenco Medical.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、腰椎側方椎体間固定術（XLIF）手術のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の腰椎側方椎体間固定術（XLIF）手術市場：タイプ別、2018年-2023年、2024年-2029年 世界の腰椎側方椎体間固定術（XLIF）手術市場：タイプ別市場シェア、2022年 ・XLIF椎体間融合システム、XLIF椎体間ケージ 世界の腰椎側方椎体間固定術（XLIF）手術市場：用途別、2018年-2023年、2024年-2029年 世界の腰椎側方椎体間固定術（XLIF）手術市場：用途別市場シェア、2022年 ・脊椎外科センター、病院、その他 世界の腰椎側方椎体間固定術（XLIF）手術市場：地域・国別、2018年-2023年、2024年-2029年 世界の腰椎側方椎体間固定術（XLIF）手術市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における腰椎側方椎体間固定術（XLIF）手術のグローバル売上、2018年-2023年 ・主要企業における腰椎側方椎体間固定術（XLIF）手術のグローバル売上シェア、2022年 ・主要企業における腰椎側方椎体間固定術（XLIF）手術のグローバル販売量、2018年-2023年 ・主要企業における腰椎側方椎体間固定術（XLIF）手術のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic Plc、 Johnson & Johnson、 Stryker Corporation、 Zimmer Biomet Holdings Inc.、 NuVasive Inc.、 Globus Medical Inc.、 DePuy Synthes、 B. Braun Melsungen AG、 Alphatec Holdings Inc.、 RTI Surgical Holdings Inc.、 K2M Group Holdings Inc.、 Orthofix Medical Inc.、 Aesculap Implant Systems、 SpineWave Inc.、 MicroPort Scientific Corporation、 Life Spine Inc.、 Captiva Spine Inc.、 CoreLink Surgical LLC、 CTL Medical Corporation、 Providence Medical Technology Inc.、 Safe Orthopaedics、 Spinal Elements Holdings Inc.、 Spineology Inc.、 Wenzel Spine Inc.、 Xenco Medical. ************************************************************* ・調査・分析レポートの概要 腰椎側方椎体間固定術（XLIF）手術市場の定義 市場セグメント 世界の腰椎側方椎体間固定術（XLIF）手術市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の腰椎側方椎体間固定術（XLIF）手術市場規模 世界の腰椎側方椎体間固定術（XLIF）手術市場規模：2022年 VS 2029年 世界の腰椎側方椎体間固定術（XLIF）手術市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの腰椎側方椎体間固定術（XLIF）手術の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の腰椎側方椎体間固定術（XLIF）手術製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：XLIF椎体間融合システム、XLIF椎体間ケージ 腰椎側方椎体間固定術（XLIF）手術のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：脊椎外科センター、病院、その他 腰椎側方椎体間固定術（XLIF）手術の用途別グローバル売上・予測 ・地域別市場分析 地域別腰椎側方椎体間固定術（XLIF）手術市場規模 2022年と2029年 地域別腰椎側方椎体間固定術（XLIF）手術売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic Plc、 Johnson & Johnson、 Stryker Corporation、 Zimmer Biomet Holdings Inc.、 NuVasive Inc.、 Globus Medical Inc.、 DePuy Synthes、 B. Braun Melsungen AG、 Alphatec Holdings Inc.、 RTI Surgical Holdings Inc.、 K2M Group Holdings Inc.、 Orthofix Medical Inc.、 Aesculap Implant Systems、 SpineWave Inc.、 MicroPort Scientific Corporation、 Life Spine Inc.、 Captiva Spine Inc.、 CoreLink Surgical LLC、 CTL Medical Corporation、 Providence Medical Technology Inc.、 Safe Orthopaedics、 Spinal Elements Holdings Inc.、 Spineology Inc.、 Wenzel Spine Inc.、 Xenco Medical. ... |
This research report provides a comprehensive analysis of the Extreme Lateral Interbody Fusion (XLIF) Surgery market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Extreme Lateral Interbody Fusion (XLIF) Surgery market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Extreme Lateral Interbody Fusion (XLIF) Surgery, challenges faced by the industry, and potential opportunities for market players.
The global Extreme Lateral Interbody Fusion (XLIF) Surgery market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Extreme Lateral Interbody Fusion (XLIF) Surgery market presents opportunities for various stakeholders, including Spinal Surgery Centers, Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Extreme Lateral Interbody Fusion (XLIF) Surgery market. Additionally, the growing consumer demand present avenues for market expansion.
The global Extreme Lateral Interbody Fusion (XLIF) Surgery market was valued at US$ 943.2 million in 2022 and is projected to reach US$ 1283.1 million by 2029, at a CAGR of 4.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Extreme Lateral Interbody Fusion (XLIF) Surgery market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Extreme Lateral Interbody Fusion (XLIF) Surgery market.
Market Overview: The report provides a comprehensive overview of the Extreme Lateral Interbody Fusion (XLIF) Surgery market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., XLIF Interbody Fusion Systems, XLIF Interbody Cages), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Extreme Lateral Interbody Fusion (XLIF) Surgery market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Extreme Lateral Interbody Fusion (XLIF) Surgery market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Extreme Lateral Interbody Fusion (XLIF) Surgery market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Extreme Lateral Interbody Fusion (XLIF) Surgery market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Extreme Lateral Interbody Fusion (XLIF) Surgery market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Extreme Lateral Interbody Fusion (XLIF) Surgery market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Extreme Lateral Interbody Fusion (XLIF) Surgery, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Extreme Lateral Interbody Fusion (XLIF) Surgery market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Extreme Lateral Interbody Fusion (XLIF) Surgery market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
XLIF Interbody Fusion Systems
XLIF Interbody Cages
Market segment by Application
Spinal Surgery Centers
Hospitals
Others
Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic Plc
Johnson & Johnson
Stryker Corporation
Zimmer Biomet Holdings Inc.
NuVasive Inc.
Globus Medical Inc.
DePuy Synthes
B. Braun Melsungen AG
Alphatec Holdings Inc.
RTI Surgical Holdings Inc.
K2M Group Holdings Inc.
Orthofix Medical Inc.
Aesculap Implant Systems
SpineWave Inc.
MicroPort Scientific Corporation
Life Spine Inc.
Captiva Spine Inc.
CoreLink Surgical LLC
CTL Medical Corporation
Providence Medical Technology Inc.
Safe Orthopaedics
Spinal Elements Holdings Inc.
Spineology Inc.
Wenzel Spine Inc.
Xenco Medical.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Extreme Lateral Interbody Fusion (XLIF) Surgery, market overview.
Chapter 2: Global Extreme Lateral Interbody Fusion (XLIF) Surgery market size in revenue.
Chapter 3: Detailed analysis of Extreme Lateral Interbody Fusion (XLIF) Surgery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Extreme Lateral Interbody Fusion (XLIF) Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Overall Market Size
2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size: 2022 VS 2029
2.2 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Extreme Lateral Interbody Fusion (XLIF) Surgery Players in Global Market
3.2 Top Global Extreme Lateral Interbody Fusion (XLIF) Surgery Companies Ranked by Revenue
3.3 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Companies
3.4 Top 3 and Top 5 Extreme Lateral Interbody Fusion (XLIF) Surgery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Extreme Lateral Interbody Fusion (XLIF) Surgery Players in Global Market
3.6.1 List of Global Tier 1 Extreme Lateral Interbody Fusion (XLIF) Surgery Companies
3.6.2 List of Global Tier 2 and Tier 3 Extreme Lateral Interbody Fusion (XLIF) Surgery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Markets, 2022 & 2029
4.1.2 XLIF Interbody Fusion Systems
4.1.3 XLIF Interbody Cages
4.2 By Type – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue & Forecasts
4.2.1 By Type – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2023
4.2.2 By Type – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2024-2029
4.2.3 By Type – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2022 & 2029
5.1.2 Spinal Surgery Centers
5.1.3 Hospitals
5.1.4 Others
5.2 By Application – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue & Forecasts
5.2.1 By Application – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2023
5.2.2 By Application – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2024-2029
5.2.3 By Application – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2022 & 2029
6.2 By Region – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue & Forecasts
6.2.1 By Region – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2023
6.2.2 By Region – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2024-2029
6.2.3 By Region – Global Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2029
6.3.2 US Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.3.3 Canada Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.3.4 Mexico Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2029
6.4.2 Germany Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.3 France Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.4 U.K. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.5 Italy Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.6 Russia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.7 Nordic Countries Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.4.8 Benelux Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2029
6.5.2 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.5.3 Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.5.4 South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.5.5 Southeast Asia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.5.6 India Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2029
6.6.2 Brazil Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.6.3 Argentina Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, 2018-2029
6.7.2 Turkey Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.7.3 Israel Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.7.4 Saudi Arabia Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
6.7.5 UAE Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size, 2018-2029
7 Extreme Lateral Interbody Fusion (XLIF) Surgery Companies Profiles
7.1 Medtronic Plc
7.1.1 Medtronic Plc Company Summary
7.1.2 Medtronic Plc Business Overview
7.1.3 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.1.4 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.1.5 Medtronic Plc Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.2.4 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Stryker Corporation
7.3.1 Stryker Corporation Company Summary
7.3.2 Stryker Corporation Business Overview
7.3.3 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.3.4 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.3.5 Stryker Corporation Key News & Latest Developments
7.4 Zimmer Biomet Holdings Inc.
7.4.1 Zimmer Biomet Holdings Inc. Company Summary
7.4.2 Zimmer Biomet Holdings Inc. Business Overview
7.4.3 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.4.4 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.4.5 Zimmer Biomet Holdings Inc. Key News & Latest Developments
7.5 NuVasive Inc.
7.5.1 NuVasive Inc. Company Summary
7.5.2 NuVasive Inc. Business Overview
7.5.3 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.5.4 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.5.5 NuVasive Inc. Key News & Latest Developments
7.6 Globus Medical Inc.
7.6.1 Globus Medical Inc. Company Summary
7.6.2 Globus Medical Inc. Business Overview
7.6.3 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.6.4 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.6.5 Globus Medical Inc. Key News & Latest Developments
7.7 DePuy Synthes
7.7.1 DePuy Synthes Company Summary
7.7.2 DePuy Synthes Business Overview
7.7.3 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.7.4 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.7.5 DePuy Synthes Key News & Latest Developments
7.8 B. Braun Melsungen AG
7.8.1 B. Braun Melsungen AG Company Summary
7.8.2 B. Braun Melsungen AG Business Overview
7.8.3 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.8.4 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.8.5 B. Braun Melsungen AG Key News & Latest Developments
7.9 Alphatec Holdings Inc.
7.9.1 Alphatec Holdings Inc. Company Summary
7.9.2 Alphatec Holdings Inc. Business Overview
7.9.3 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.9.4 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.9.5 Alphatec Holdings Inc. Key News & Latest Developments
7.10 RTI Surgical Holdings Inc.
7.10.1 RTI Surgical Holdings Inc. Company Summary
7.10.2 RTI Surgical Holdings Inc. Business Overview
7.10.3 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.10.4 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.10.5 RTI Surgical Holdings Inc. Key News & Latest Developments
7.11 K2M Group Holdings Inc.
7.11.1 K2M Group Holdings Inc. Company Summary
7.11.2 K2M Group Holdings Inc. Business Overview
7.11.3 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.11.4 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.11.5 K2M Group Holdings Inc. Key News & Latest Developments
7.12 Orthofix Medical Inc.
7.12.1 Orthofix Medical Inc. Company Summary
7.12.2 Orthofix Medical Inc. Business Overview
7.12.3 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.12.4 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.12.5 Orthofix Medical Inc. Key News & Latest Developments
7.13 Aesculap Implant Systems
7.13.1 Aesculap Implant Systems Company Summary
7.13.2 Aesculap Implant Systems Business Overview
7.13.3 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.13.4 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.13.5 Aesculap Implant Systems Key News & Latest Developments
7.14 SpineWave Inc.
7.14.1 SpineWave Inc. Company Summary
7.14.2 SpineWave Inc. Business Overview
7.14.3 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.14.4 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.14.5 SpineWave Inc. Key News & Latest Developments
7.15 MicroPort Scientific Corporation
7.15.1 MicroPort Scientific Corporation Company Summary
7.15.2 MicroPort Scientific Corporation Business Overview
7.15.3 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.15.4 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.15.5 MicroPort Scientific Corporation Key News & Latest Developments
7.16 Life Spine Inc.
7.16.1 Life Spine Inc. Company Summary
7.16.2 Life Spine Inc. Business Overview
7.16.3 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.16.4 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.16.5 Life Spine Inc. Key News & Latest Developments
7.17 Captiva Spine Inc.
7.17.1 Captiva Spine Inc. Company Summary
7.17.2 Captiva Spine Inc. Business Overview
7.17.3 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.17.4 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.17.5 Captiva Spine Inc. Key News & Latest Developments
7.18 CoreLink Surgical LLC
7.18.1 CoreLink Surgical LLC Company Summary
7.18.2 CoreLink Surgical LLC Business Overview
7.18.3 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.18.4 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.18.5 CoreLink Surgical LLC Key News & Latest Developments
7.19 CTL Medical Corporation
7.19.1 CTL Medical Corporation Company Summary
7.19.2 CTL Medical Corporation Business Overview
7.19.3 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.19.4 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.19.5 CTL Medical Corporation Key News & Latest Developments
7.20 Providence Medical Technology Inc.
7.20.1 Providence Medical Technology Inc. Company Summary
7.20.2 Providence Medical Technology Inc. Business Overview
7.20.3 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.20.4 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.20.5 Providence Medical Technology Inc. Key News & Latest Developments
7.21 Safe Orthopaedics
7.21.1 Safe Orthopaedics Company Summary
7.21.2 Safe Orthopaedics Business Overview
7.21.3 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.21.4 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.21.5 Safe Orthopaedics Key News & Latest Developments
7.22 Spinal Elements Holdings Inc.
7.22.1 Spinal Elements Holdings Inc. Company Summary
7.22.2 Spinal Elements Holdings Inc. Business Overview
7.22.3 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.22.4 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.22.5 Spinal Elements Holdings Inc. Key News & Latest Developments
7.23 Spineology Inc.
7.23.1 Spineology Inc. Company Summary
7.23.2 Spineology Inc. Business Overview
7.23.3 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.23.4 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.23.5 Spineology Inc. Key News & Latest Developments
7.24 Wenzel Spine Inc.
7.24.1 Wenzel Spine Inc. Company Summary
7.24.2 Wenzel Spine Inc. Business Overview
7.24.3 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.24.4 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.24.5 Wenzel Spine Inc. Key News & Latest Developments
7.25 Xenco Medical.
7.25.1 Xenco Medical. Company Summary
7.25.2 Xenco Medical. Business Overview
7.25.3 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Major Product Offerings
7.25.4 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue in Global Market (2018-2023)
7.25.5 Xenco Medical. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
